Status:
COMPLETED
Body Composition Monitoring for Determination of the Fluid Status in Volunteers Undergoing Intravenous Fluid Therapy
Lead Sponsor:
Medical University of Vienna
Conditions:
Fluid Shifts
Body Fluid Compartments
Eligibility:
MALE
18-50 years
Phase:
NA
Brief Summary
This volunteer study tests a recently developed whole-body bioimpedance spectroscopy device called Body Composition Monitor (BCM) which measures the body composition (i.e. the water content of the bod...
Detailed Description
Technically assisted assessment of volume status may be useful to direct fluid administration. As a prerequisite the investigators will test a recently developed whole-body bioimpedance spectroscopy ...
Eligibility Criteria
Inclusion
- Healthy male volunteers aged between 18 and 50 years
- BMI \< 30 kg/m2
- Written informed consent given by volunteers after being provided with detailed information about the nature, risks, and scope of the clinical study
Exclusion
- Implanted pacemaker or defibrillator
- Limb amputation identified by physical examination
- Known allergy or hypersensitivity to Elo-Mel
- Abnormalities in Blood pressure (Hypotension with a systolic BP \< 90 mmHg and hypertension with a systolic BP \> 160 mmHg) after 5 min resting
- Cardiac insufficiency (NYHA≥ 2)
- Renal insufficiency (GFR ≤ 60 ml/min)
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02296294
Start Date
October 1 2014
End Date
July 1 2016
Last Update
July 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Vienna, Austria, 1090